A Randomized, Double-blind, Parallel, Placebo-Controlled, Study to Evaluate the Safety and Tolerability of Oral GW677954 Capsules (15 mg) in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus.

Trial Profile

A Randomized, Double-blind, Parallel, Placebo-Controlled, Study to Evaluate the Safety and Tolerability of Oral GW677954 Capsules (15 mg) in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Insulin; Sodelglitazar
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Nov 2010 Planned number of patients changed from 116 to 1 as reported by ClinicalTrials.gov.
    • 19 Nov 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 15 Oct 2008 Actual start date changed from Aug 2006 to Sep 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top